| abstract |
FIELD: medicine. n SUBSTANCE: group of inventions relates to methods for determining whether individual suffering cancer disease, positive at mutations ALK, respond to ALK inhibitor treatment, and/or whether there is probability that patient suffering cancer disease, such disease is progressing slower, as well as to kit. n EFFECT: group of inventions enables assessing efficacy of treating cancer based on identification of new mutations in anaplastic lymphoma kinase. n 30 cl, 5 dwg, 1 tbl, 4 ex |